Geneuro
GEM | PA
Overview
Corporate Details
- ISIN(s):
- CH0308403085
- LEI:
- 213800FUJCKXO9LK3444
- Country:
- Switzerland
- Address:
- chemin du Pré-Fleuri 3, 1228 Plan-les-Ouates
- Website:
- https://geneuro.ch/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Geneuro, headquartered in Switzerland, is a biotechnology company developing treatments for neurological and autoimmune diseases.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-30 19:37 |
Declaration of Voting Results & Voting Rights Announcements
Inside Information / Other news releases
|
English | 224.5 KB | |
| 2025-06-30 19:37 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 753.1 KB | |
| 2025-06-12 22:42 |
Regulatory News Service
Inside Information / Other news releases
|
English | 204.9 KB | |
| 2025-06-12 22:42 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 203.8 KB | |
| 2025-06-10 18:24 |
General Meeting Notice
Informations privilégiées / Autres communiqués
|
French | 207.4 KB | |
| 2025-06-10 18:24 |
Inside Information Statement
Inside Information / Other news releases
|
English | 209.5 KB | |
| 2025-05-27 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 162.5 KB | |
| 2025-05-27 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 187.1 KB | |
| 2025-05-12 18:36 |
Regulatory News Service
Inside Information / Other news releases
|
English | 481.8 KB | |
| 2025-05-12 18:36 |
Inside Information Statement
Informations privilégiées / Autres communiqués
|
French | 669.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Theradiag | France | ALTER | |
|
Theranexus | France | ALTHX | |
|
Thor Medical ASA | Norway | NANOV | |
|
TME Pharma N.V. | Germany | ALTME | |
|
Toleranzia AB | Sweden | TOL | |
|
Transgene | France | TNG | |
|
Tvardi Therapeutics Inc. | United States of America | TVRD | |
|
Ulisse Biomed | Italy | UBM | |
| Uni-Bio Science Group Ltd | Hong Kong | N/A | ||
|
Univo Pharmaceuticals Ltd. | Israel | UNVO-M |